IBB
iShares NASDAQ Biotechnology ETFIBB Fund Description
IBB tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
IBB Factset Analytics Insight
The coverage offered by hugely popular IBB differs dramatically from most peer funds. It tracks a market-cap-weighted index of NASDAQ-listed biotech companies, while most peer funds use alternative weighting schemes. IBB’s cap-weighting produces a basket that heavily favors large-caps and concentrates exposure in top 10 names. IBB also differs from some peer funds and our segment benchmark in its emphasis on pharmaceuticals. Since the fund can only hold companies traded on the NASDAQ, IBB may miss opportunities in companies traded on the NYSE, which several of the other biotech funds are eligible to hold. This extremely large and liquid product has a good history of tracking its underlying index and does so at a cost towards the lower end of its segment.
IBB MSCI ESG Analytics Insight
iShares NASDAQ Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 4.22 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares NASDAQ Biotechnology ETF ranks in the 23th percentile within its peer group and in the 35th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
IBB CHARTS AND PERFORMANCE
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
-
IBB Top 10 Countries
IBB Top 10 Sectors
IBB Top 10 Holdings [View All]
IBB Summary Data
IBB Portfolio Data
IBB Index Data
IBB Portfolio Management
IBB Tax Exposures
IBB Fund Structure
IBB Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of IBB. IBB is rated a 5 out of 5.
IBB Tradability
IBB Sector/Industry Breakdown
IBB
IBB TOP 10 HOLDINGS[View All]
IBB Countries
IBB
IBB Regions
IBB
IBB Economic Development
IBB
IBB Performance Statistics
IBB MSCI ESG Ratings
IBB BENCHMARK COMPARISON SUMMARY
IBB
IBB BENCHMARK COMPARISON MARKET CAP SIZE
IBB
Options Strategies for Outcome Investing
Options allow you to customize investment outcomes. Using the strategy builders provided by Cboe Vest Technologies, you can construct some of the most common option strategies. Check out our user guide for more information on how to use the tool.
A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.
The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.
ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.
[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
Data provider:
Terms of Use
MSCI ESG Research LLC’s ("MSCI ESG") Fund Metrics products (the "Information") provide environmental, social and governance data with respect to underlying securities within more than 24,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted to, nor received approval from, the US SEC or any other regulatory body. None of the Information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided "as is" and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information.